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Abstract
This study was designed to evaluate the influence of phosphorus (P) restriction on the dele-
terious effects of high fat diets on mineral metabolism. Twenty-four rats were allotted to 3
groups (n = 8 each) that were fed different diets for 7 months. Rats in group 1 were fed nor-
mal fat-normal P (0.6%) diet (NF-NP), rats in group 2 were fed high fat- normal P diet (HF-
NP) and rats in group 3 were fed high fat-low P (0.2%) diet (HF-LP). Blood, urine and tissues
were collected at the end of the experiments. When compared with the control group (NF-
NP), rats fed HF diets showed increases in body weight, and in plasma concentrations of tri-
glycerides and leptin, and decreased plasma calcitriol concentrations. In rats fed HF-NP
plasma fibroblast growth factor 23 (FGF23) was higher (279.6±39.4 pg/ml vs 160.6±25.0
pg/ml, p = 0.018) and renal klotho (ratio klotho/GAPDH) was lower (0.75±0.06 vs 1.06±0.08,
p<0.01) than in rats fed NF-NP. Phosphorus restriction did not normalize plasma FGF23 or
renal klotho; in fact, rats fed HF-LP, that only ingested an average of 22.9 mg/day of P, had
higher FGF23 (214.7±32.4 pg/ml) concentrations than rats fed NF-NP (160.6±25.0 pg/ml),
that ingested and average of 74.4 mg/day of P over a 7 month period. In conclusion, our
results demonstrate that severe P restriction over a prolonged period of time (7 months)
does not normalize the increase in circulating FGF23 induced by HF diets. These data indi-
cate that the deleterious effects of high fat diet on the FGF23/klotho axis are not eliminated
by reduced P intake.
Introduction
Obesity and its related metabolic complications represent a major health concern, not only
due to their influence on morbidity and mortality but also for the high healthcare cost associ-
ated to this disease [1,2]. A major factor in the development of obesity is excessive caloric
intake which is favored by the ingestion of energy-dense processed foods (fast food). In addi-
tion to their high caloric concentration, processed foods are often rich in phosphate (P) [3].
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Phosphate is a common food additive and the inorganic P added to processed foods is more
readily absorbed than organic P [4]. Moreover, the high fat content of many fast foods also
enhances intestinal P absorption [5]. Therefore, individuals eating fast food often ingest an
overload of P that must be excreted by the kidney to maintain P homeostasis.
Fibroblast growth factor 23 (FGF23) is a major phosphaturic hormone. In the kidney,
FGF23 promotes P excretion after binding to its receptor (FGFR1) and co-receptor (klotho)
[6]. Increased levels of FGF23, which are usually found in hyperphosphatemic uremic patients,
have been reported as a risk factor of cardiovascular mortality [7]. The relationship between
high FGF23 and mortality is not restricted to patients with kidney disease but has also been
identified in the general population [8,9].
An increase in circulating levels of FGF23 has been reported in rats fed high fat diets [10].
The mechanism for increased FGF23 production seems to be related to decreased expression
of renal klotho after feeding high fat diet. Klotho down-regulation generates tubular resistance
to FGF23 and thus more FGF23 is needed for P excretion [11]. Additionally, a recent study has
shown that an excessive tubular load of P down-regulates the expression of klotho in the kid-
ney. Renal klotho was reduced in rats with increased tubular load of P and was higher in ure-
mic rats on a low P diet than in uremic rats in a high P diet [12].
We hypothesize that reducing P load by feeding a diet with low P content would prevent
the decrease in renal klotho and the increase in FGF23 elicited by high fat diet. Thus the main
objective of this study was to evaluate the influence of P restriction on the deleterious effects of
high fat diets on mineral metabolism. Additionally, since previous studies [10] were of short
duration (1 month), a secondary objective was to evaluate the influence of high fat diets on
FGF23 over a more extended period of time (7 months).
Material and methods
Ethics
All experimental protocols were reviewed and approved by the Ethics Committee for Animal
Research of the University of Cordoba (Cordoba, Spain). All protocols were carried out in
accordance with the approved guidelines. They followed the guiding principle laid down by
the Higher Council of Scientific Research of Spain following the normal procedures directing
animal welfare (Real Decreto 223/88, BOE of 18 of March) and adhered to the recommenda-
tions included in the Guide for Care and Use of Laboratory Animals (US Department of
Health and Human Services, NIH) and European laws and regulations on protection of ani-
mals, under the advice of specialized personnel.
Animals and diets
Twenty-four 2 months-old Wistar rats, provided by the Animal Housing Facilities of the Uni-
versity of Cordoba (Cordoba, Spain), were housed with a 12h/12h light/dark cycle. Appropri-
ate measures were taken to ensure animal welfare and to address the basic behavioral and
physiological needs of rats.
Two diets with normal P (NP = 0.6%) were used in the experiments: normal fat content
diet (NF-NP) with a 5% fat concentration that provided Metabolizable Energy = 3518 kcal/kg
(Altromin C 1090–10, AltrominSpezialfutter GmbH, Germany) and a high fat content diet
(HF-NP) with a 35% fat concentration that provided Metabolizable Energy = 5241 kcal/kg
(Altromin C 1090–60, AltrominSpezialfutter GmbH, Germany). In addition, a HF diet with
low P (LP = 0.2%) was also used (HF-LP). All diets contained 0.6% of Ca and 500 IU/g of vita-
min D.
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Experimental design
Rats were allotted to 3 groups (n = 8 each) which were fed ad libitum the study diets for 7
months. Rats in group 1 were fed NF-NP, rats in group 2 were fed HF-NP and rats in group 3
were fed HF-LP. During the last week of the trial the rats were housed in metabolic cages,
allowing daily control of food and water intake and collection of urine. At the end of the exper-
iment, rats were sacrificed by exsanguination under general anesthesia (inhaled sevoflurane)
to obtain blood and tissue samples.
Blood chemistries
Blood was collected from the abdominal aorta at the time of sacrifice. Blood glucose was mea-
sured immediately after collection with a blood glucose meter (Bayer Consumer Care AG,
Basel, Switzerland). Afterwards, plasma was separated by centrifugation and stored at –20˚C
until assayed. Plasma concentrations of total cholesterol, triglycerides, urea, creatinine, cal-
cium and phosphorus were measured by spectrophotometry (BioSystems SA, Barcelona,
Spain). ELISA tests were used to quantify plasma intact FGF23 (Immutopics, San Clemente,
CA), leptin (Millipore Corporation, Billerica, MA, USA), tumor necrosis factor alpha (TNFα)
(eBioscience, Bender MedSystems GmbH, Vienna, Austria) and parathyroid hormone (PTH)
(Immutopics, San Clemente, CA). Radioimmunoassay (Immunodiagnostic Systems Ltd, Bol-
don, UK) was used in plasma samples to determine 1,25-dihydroxyvitamin D (calcitriol).
Urine chemistries
Urine phosphorus concentrations were measured by spectrophotometry (BioSystems SA, Bar-
celona, Spain).
Real-Time-Polymerase Chain Reaction (RT-PCR)
Analyses of renal klotho mRNA were performed by quantitative Real-Time PCR. Kidney tissue
was disrupted using liquid nitrogen and grinded thoroughly with a mortar. Renal total RNA
was extracted with using chloroform and isopropanol precipitation method and a treatment
with DNAse I amplification Grade (Sigma-Aldrich) and quantified by spectrophotometry
(ND-1000, Nanodrop Technologies, Wilmington, DE). Fifty ng of total RNA were used to ana-
lyze mRNA expression in the Light Cycler thermal cycler system (Roche Diagnostics, India-
napolis, IN, USA). RT-PCR was performed in one step, with the QuantiTect SYBR Green
RT-PCR kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s protocol. Rat
primers for membrane Klotho were designed with the free Oligo 7 software (http://www.oligo.
net/), and the sequence is F: 5´-CTCTGAAAGCCTACGTGTTGG-3´ and R: 5´-TAGAAAC
GAGATGAAGGCCAG-3´. Results were normalized to that of GAPDH. Primers sequence for
GAPDH is F: 5´-AGGGCTGCCTTCTCTTGTGAC-3´ and R: 5´-TGGGTAGAATCATACTG
GAACATGTAG-3´. Quantification of relative expression was determined by the 2(2ΔCt)
method.
Protein extraction and Western blot analysis
Proteins were isolated from renal tissue by using a lysis buffer containing HEPES (10 mmol/l),
KCl (10 mmol/l), EDTA (0.1 mmol/l), EGTA (0.1 mmol/l), DTT (1 mmol/l), PMSF (0.5
mmol/l), protease inhibitor cocktail (70 μg/ml), and I-Gepal CA-630 (0.6%), pH 7.9 (Sigma
Aldrich, St. Louis, MO). Protein concentration was determined by Bradford method. For
Western Blot analysis, 50 μg of protein (klotho) or 100 μg (NaPiIIa) of protein were electro-
phoresed on a 10% SDS-polyacrilamide gel (Invitrogen, Carlsbad, CA) and electrophoretically
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transferred (Transfer Systems, BioRad, Hercules, CA) from the gels onto nitrocellulose mem-
branes (Invitrogen). The following steps were performed with gentle shaking. Membranes
were incubated in TTBS-L solution [20 mM Tris-HCl (pH 7.6), 0.2% Tween 20, 150 mM
NaCl] (Sigma Aldrich), and 5% nonfat dry milk (Bio-Rad) at room temperature for 1 hour to
avoid nonspecific binding. Membranes were then washed with TTBS buffer (the same compo-
sition as TTBS-L without nonfat dry milk) and incubated overnight at 4˚C temperature with a
rat anti-klotho antibody (Alpha Diagnostic Int, San Antonio, TX; 0.5 μg/ml) or a rabbit poly-
clonal anti-NaPiIIa antibody (Abcam plc, Cambridge, UK; 1 μg/ml). The membranes were
then washed with TTBS buffer and immunolabeled using a peroxidase-conjugated secondary
antibody (1:5000 dilution; Santa Cruz Biotechnology Inc, Santa Cruz, CA). Finally, they were
revealed on autoradiographic film using ECL Plus Western Blotting Detection System (GE
Healthcare, Piscataway, NJ). GAPDH was used as housekeeping protein to ensure equal load-
ing of the gels. Protein levels were quantified using ImageJ software (National Institutes of
Health, Bethesda, MD).
Renal histopathology
Kidney tissue samples were fixed in 10% buffered formalin, embedded in paraffin, sectioned
and processed for staining with hematoxylin and eosin (H&E), periodic acid-Schiff (PAS),
Masson’s Trichrome and Von Kossa stains. Lesions were scored using a semi quantitative
scale graded from 0–3: 0 (absent), 1 (slight), 2 (moderate) or 3 (severe). This scale was con-
structed by a previous scanning of all the samples under study in which the more severe lesions
were identified and were assigned a value = 3. For statistical analysis lesions were grouped into
three categories: a) glomerular lesions (glomerular retraction and sclerosis), b) tubular lesions
(tubular atrophy, tubular hyperplasia and thickening of basement membrane) and c) intersti-
tial lesions (interstitial edema and inflammatory infiltrate). Analyses were performed in a
blind manner.
Statistics
Values are expressed as the mean ± standard error (SE). The difference between means for the
three experimental groups was assessed by ANOVA. Fisher LSD test was used as a post-hoc
procedure. A correlation study was carried out using the Pearson test. p<0.05 was considered
significant.
Results
At the beginning of the study all rats had similar body weight that ranged between 239.4±1.7
and 251.2±3.3 g. During the 7 months that lasted the experiment rats experienced an increase
in body weight that was more accentuated in the groups fed a HF diet. Phosphorus restriction
attenuated the increase in body weight in rats fed HF, but the differences were small and non-
significant (Fig 1). Mean daily intake of P (mg/day) was not influenced by the amount of
ingested fat but, obviously, was much lower (p<0.001) in the P restricted group: NF-NP = 74.4
±6.3, HF-NP = 77.9±3.7, HF-LP = 22.9±1.4.
Blood glucose and cholesterol concentrations were not different between groups. However,
plasma triglycerides were higher in rats fed HF than in rats fed NF: HF-NP = 0.94±0.1 mmol/l
vs NF-NP = 0.58±0.1 mmol/l, p = 0.002. Phosphorus restriction led to a non-significant
decrease in triglyceride concentrations in HF rats. Plasma leptin concentrations were also
higher (p<0.05) in rats fed HF (5.2±0.8 and 5.8±0.5 ng/ml) than in rats fed NF (3.9±0.5 ng/ml)
and were not influenced by P restriction; these data are depicted in Table 1.
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Plasma Ca concentrations were not different in the study groups. Plasma P was not influ-
enced by the caloric content of the diet: NF-NP = 1.2±0.1 mmol/l vs HF-NP = 1.0±0.1 mmol/l.
Phosphorus restriction did not modify plasma P in rats fed HF (1.0±0.1 mmol/l). Plasma PTH
was not different in HF vs NF groups but tended to be decreased in the HF-LP group. Plasma
calcitriol concentrations were higher in rats fed normal fat: NF-NP = 50.7±21.5 pmol/l vs
HF-NP = 5.3±0.9 pmol/l, p<0.05. Phosphorus restriction led to a modest increase in plasma
calcitriol in rats fed high fat, HF-LP = 12.3±1.9 pmol/l, p<0.05 vs HF-NP. No significant dif-
ferences in either urea or creatinine were observed between the experimental groups, although
rats fed HF had slightly higher values of both parameters. Plasma concentration of TNFα
tended to be higher in rats fed HF (75.5±7.6 and 77.7±4.5 pg/ml) when compared with rats fed
NF (62.7±4.6 pg/ml) but differences were not significant (Table 1).
Plasma concentrations of FGF23 were higher in the HF groups but significant differences
were only found between HF-NP, 279.6±39.4 pg/ml and NF-NP, 160.6±25.0 pg/ml (p = 0.018).
A non-significant tendency to decreased FGF23 was detected in P restricted rats (Fig 2A).
Renal klotho, both at the mRNA and protein levels, changed in accordance, but in opposite
direction, to FGF23. Thus, mRNA (ratio klotho/GAPDH) was lower (p<0.01) in rats fed
Fig 1. Body weight. Increase in body weight after the 7 months that lasted the experiments in rats (n = 8 per group)
fed diets with normal fat and normal phosphorus (NF-NP), high fat and normal phosphorus (HF-NP) and high fat and
low phosphorus (HF-LP). ap<0.05 vs NF-NP.
https://doi.org/10.1371/journal.pone.0198481.g001
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HF-NP (0.65±0.09) than in rats fed NF-NP (1.06±0.13). A significant (p<0.01) decrease in
renal klotho protein (ratio klotho/GAPDH) was also found in the HF-NP group (0.75±0.06)
when compared with the NF-NP group (1.06±0.08) (Fig 3).
Urinary excretion of P was higher (p<0.01) in rats fed HF-NP (33.5±1.7 mg/day) than in
rats fed NF-NP (23.8±0.8 mg/day). Rats fed HF-LP excreted very little P (3.5±0.6) mg/day,
p<0.01 vs NP groups (Fig 2B). Renal NaPiIIa (ratio NaPiIIa/GAPDH) was decreased (p<0.01)
in rats fed HF-NP (0.59±0.05) when compared with rats fed NF-NP (1.04±0.04). Phosphorus
restriction restored NaPiIIa expression in rats fed HF to values (0.94±0.09) than were not dif-
ferent from rats fed NF (Fig 2C).
In rats fed HF, the amount of P ingested was well correlated (r2 = 0.663) with urinary excre-
tion of P (Fig 4A). However, no significant correlation was found between ingested P and
either plasma P or FGF23 (Fig 4B and 4C).
Histopathological studies demonstrated the presence of subtle renal lesions in rats fed HF
diets. The number of retracted and sclerotic glomeruli was significantly higher in rats fed HF
and P restriction did not influence glomerular damage. Similarly, rats fed HF showed more
tubular atrophy and hyperplasia, as well as thickening of the basement membrane than rats fed
NF. Phosphorus restriction tended to attenuate tubular lesions but the differences were not
significant. Interstitial edema and infiltrate were also more prominent in rats fed HF and, in
this case, P restriction significantly attenuated interstitial pathology (Table 2). Neither fibrosis
nor nephrocalcinosis were detected in any experimental group.
Discussion
This study was designed to investigate the effect of restricting P intake on the changes in min-
eral metabolism elicited by HF diets. Our results demonstrate that marked P restriction over a
prolonged period of time (7 months) does not normalize the elevated circulating FGF23 levels
induced by HF diets. These data indicate that the deleterious effects of high fat diet on the
FGF23/klotho axis are not eliminated by reduced P intake.
The increase in plasma concentrations of FGF23 detected in the present study after feeding
HF diets confirms previous results which were obtained over a much shorter period of time (1
month) [10]. It is interesting to note that the magnitude of changes in both plasma FGF23 and
Table 1. Blood biochemistry. Plasma concentrations of parameters related to energy metabolism, mineral metabolism, renal function, and inflammation in rats fed diets







Glucose (mmol/l) 6.43 ± 0.3 5.54 ± 0.3 5.76 ± 0.2
Total Cholesterol (mmol/l) 1.31 ± 0.2 1.28 ± 0.2 1.37 ± 0.1
Triglycerides (mmol/l) 0.58 ± 0.1 0.94 ± 0.1a 0.63 ± 0.0
Leptin (ng/ml) 3.9 ± 0.5 5.2 ± 0.8a 5.8 ± 0.5a
Calcium (mmol/l) 2.3 ± 0.1 2.2 ± 0.1 2.2 ± 0.1
Phosphorus (mmol/l) 1.2 ± 0.1 1.0 ± 0.1 1.0 ± 0.1
PTH (pmol/l) 29.8 ± 6.5 27.5 ± 6.0 21.0 ± 1.6
Calcitriol (pmol/l) 50.7 ± 21.5 5.3 ± 0.9a 12.3 ± 1.9ab
Urea (mmol/l) 3.98 ± 0.51 4.98 ± 0.54 4.99 ± 0.44
Creatinine (μmol/l) 65 ± 4 73 ± 3 81 ± 2
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renal klotho was similar after 1 and 7 months of exposure to HF diets. Thus the effect of HF
diets on these parameters does not seem to be progressive.
As it has been previously reported, the mechanism for increased FGF23 in rats fed HF diets
is likely related to the decrease in renal klotho. Renal klotho has been shown to decrease in
response to HF diets both in Wistar rats [10] and in APoE knockout mice [13]. When renal
Fig 2. Plasma FGF23, urinary excretion of P and renal NaPiIIa. (A) Circulating concentrations of FGF23 in rats
(n = 8 per group) fed diets with normal fat and normal phosphorus (NF-NP), high fat and normal phosphorus
(HF-NP) and high fat and low phosphorus (HF-LP). (B) Urinary excretion of P (mg/day) in rats (n = 8 per group) fed
diets with normal fat and normal phosphorus (NF-NP), high fat and normal phosphorus (HF-NP) and high fat and
low phosphorus (HF-LP). (C) Expression of NaPiIIa in the kidneys of rats (n = 8 per group) fed diets with normal fat
and normal phosphorus (NF-NP), high fat and normal phosphorus (HF-NP) and high fat and low phosphorus
(HF-LP). The original gel from which blots have been extracted is shown in S1 Fig. ap<0.05 vs NF-NP, bp<0.05 vs
HF-NP.
https://doi.org/10.1371/journal.pone.0198481.g002
High fat diet, phosphorus and FGF23
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klotho is decreased, tubular resistance to FGF23 action ensues and more FGF23 is needed to
maintain phosphaturia, consequently resulting in an increase in circulating levels of FGF23
[11]. In addition, feeding high fat and obesity may elicit systemic inflammation [14] and
renal injury [15] which could also influence FGF23 [11]. In the present study, a tendency to
increased TNFα and minor renal lesions were observed in rats fed HF. Therefore, in addition
to the reduction in renal klotho, both inflammation and renal damage may have played a mar-
ginal role in the increase in FGF23.
Fig 3. Renal klotho. Klotho mRNA (A) and protein (B) in the kidneys of rats (n = 8 per group) fed diets with normal
fat and normal phosphorus (NF-NP), high fat and normal phosphorus (HF-NP) and high fat and low phosphorus
(HF-LP). The original gel from which blots have been extracted is shown in S2 Fig. ap<0.05 vs NF-NP.
https://doi.org/10.1371/journal.pone.0198481.g003
High fat diet, phosphorus and FGF23
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Fig 4. Diet vs urine & plasma P and FGF23. Correlation between P ingested and (A) P urine (r2 = 0.663, p<0.001),
(B) P plasma (r2 = 0.004, p = 0.806), and (C) FGF23 plasma (r2 = 0.130, p = 0.187) in rats fed high fat diets with normal
and low phosphorus content.
https://doi.org/10.1371/journal.pone.0198481.g004
High fat diet, phosphorus and FGF23
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Based on recent published data that demonstrated that klotho expression in the kidney is
regulated by the P load in the renal tubule [12], it was hypothesized that reducing P intake,
by feeding a 0.2% P diet, would restore renal klotho and decrease circulating FGF23 levels in
rats fed HF. Our results show that P restriction resulted in a discrete increase in renal klotho
expression in rats fed HF diets. A small and non-significant decrease in circulating levels of
FGF23 was also observed in rats fed HF diets after P restriction. These results support previous
data on the role of tubular P load on klotho but, on the other hand, demonstrate that P restric-
tion is not able to fully compensate the changes in FGF23 elicited by feeding a HF diet. In fact,
in this model the stimulatory effect of HF diet on FGF23 overcame the inhibitory effect of P
restriction and the present data point towards a preferential regulation of FGF23 by fat intake
rather than by P intake, as demonstrated by direct comparison of HF-LP and NF-NP groups.
This contention is illustrated by the fact that rats fed HF-LP, that only ingested an average of
22.9 mg/day of P, had higher FGF23 concentrations than rats fed NF-NP, that ingested and
average of 74.4 mg/day of P over a 7 month period.
The main physiologic role of FGF23 is to enhance phosphaturia [6] and this is accom-
plished by down-regulating P transporters, mainly NaPiIIa, in the renal tubule. The reduction
of NaPiIIa restricts P reabsorption and promotes urinary excretion of P [16]. In our study,
NaPiIIa was regulated in accordance to the changes in FGF23. Therefore, feeding HF resulted
in a significant decrease in NaPiIIa and increased urinary excretion of P. Interestingly, in rats
fed HF, P restriction increased NaPiIIa to almost to the same level than in rats fed NF, contrary
to what was observed with FGF23. These data are in agreement with previous reports suggest-
ing that, in addition to FGF23, NaPiIIa may be directly regulated by P [17].
It is surprising that high fat intake has such a profound influence on FGF23. It remains to
be determined to what point FGF23 regulation by fat intake is an epiphenomenon or a reflec-
tion of further, and as yet not clarified, physiologic actions of FGF23. FGF23 plays a pivotal
role in mineral metabolism and is consistently increased in patients with chronic kidney dis-
ease [18]. In addition, FGF23 has been reported to be increased in obese people [19] and a
recent study identified energy intake as a potential predictor of plasma FGF23 concentrations
[20]. In this context it is relevant to point out that klotho has been shown to be implicated in
energy metabolism [21,22].
Parameters related to energy intake may influence the increase in FGF23 after feeding
HF diets. One factor that might be relevant is the increase in plasma leptin concentrations
observed in rats fed HF. Leptin has been reported to stimulate FGF23 secretion by osteocytes
[23]. The effect of leptin is mediated by up-regulation of the stimulatory action of calcitriol on
skeletal synthesis of FGF23 [24]. However, in the present study, in agreement with previous
Table 2. Renal histopathology. Glomerular retraction and sclerosis (Glomerular lesions); tubular atrophy, hyperpla-
sia and thickening of basement membrane (Tubular lesions); and interstitial edema and infiltrate (Interstitial lesions)
in rats fed diets with normal fat and normal phosphorus (NF-NP), high fat and normal phosphorus (HF-NP) and high







Glomerular lesions 0.5 ± 0.1 1.1 ± 0.3a 1.3 ± 0.4a
Tubular lesions 0.1 ± 0.1 1.2 ± 0.1a 0.9 ± 0.2a
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data [10,25], calcitriol levels were very low in rats fed HF diets deeming unlikely a leptin-medi-
ated stimulatory effect of calcitriol as responsible for the increase in FGF23. Actually, since
FGF23 is known to decrease calcitriol synthesis through inhibition of 1-alpha-hydroxylase
activity in the kidney [26], it seems more likely that the high FGF23 may be responsible for the
low calcitriol concentrations in rats fed HF diets.
A remarkable finding of this study is that plasma concentrations of P did not change in rats
fed different amounts of P. Plasma P was maintained constant by adjusting urinary excretion
of P which showed an excellent correlation with P ingestion. However, it is interesting to note
that FGF23 had a poor correlation with ingested P and that many rats fed HF-LP had high
FGF23 concentrations, even though their urinary excretion of P was consistently low. This
finding also points toward a regulation of FGF23 by high fat diet, independent of P intake.
In conclusion, the results of this study indicate that dietary P restriction did not prevent the
increase in FGF23 elicited by feeding HF diets.
Supporting information
S1 Fig. Renal NaPiIIa Western blot. Original Western blot gel from which the immunoblots
shown in Fig 2 were extracted.
(DOCX)
S2 Fig. Renal klotho Western blot. Original Western blot gel from which the immunoblots
shown in Fig 3 were extracted.
(DOCX)
Acknowledgments
The authors would like to thank Dr. Vı́ctor Sorribas for useful advice on NaPiIIa measurements.
Author Contributions
Conceptualization: Ignacio Lopez, Mariano Rodriguez, Escolastico Aguilera-Tejero.
Data curation: Rafael Rios, Carmen Pineda, Juan Muñoz-Castañeda, Mariano Rodriguez.
Formal analysis: Rafael Rios, Carmen Pineda, Ana I. Raya.
Funding acquisition: Escolastico Aguilera-Tejero.
Investigation: Rafael Rios, Carmen Pineda, Ignacio Lopez, Juan Muñoz-Castañeda.
Methodology: Rafael Rios, Carmen Pineda, Juan Muñoz-Castañeda, Ana I. Raya.
Project administration: Mariano Rodriguez, Escolastico Aguilera-Tejero.
Resources: Ignacio Lopez, Mariano Rodriguez, Ana I. Raya.
Software: Ignacio Lopez.
Supervision: Mariano Rodriguez.
Validation: Mariano Rodriguez, Escolastico Aguilera-Tejero, Ana I. Raya.
Visualization: Ana I. Raya.
Writing – original draft: Ignacio Lopez, Escolastico Aguilera-Tejero.
Writing – review & editing: Rafael Rios, Carmen Pineda, Juan Muñoz-Castañeda, Mariano
Rodriguez, Escolastico Aguilera-Tejero, Ana I. Raya.
High fat diet, phosphorus and FGF23
PLOS ONE | https://doi.org/10.1371/journal.pone.0198481 June 1, 2018 11 / 13
References
1. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the pro-
jected obesity trends in the USA and the UK. Lancet. 2011; 378:815–25. https://doi.org/10.1016/S0140-
6736(11)60814-3 PMID: 21872750
2. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing coun-
tries. Nutr Rev. 2012; 70:3–21. https://doi.org/10.1111/j.1753-4887.2011.00456.x PMID: 22221213
3. Sarathy S, Sullivan C, Leon JB, Sehgal AR. Fast food, phosphorus-containing additives, and the renal
diet. J Ren Nutr. 2008; 18:466–70. https://doi.org/10.1053/j.jrn.2008.05.007 PMID: 18721742
4. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in
nephrology? Semin Dial. 2003; 16:186–8. PMID: 12753675
5. Frommelt L, Bielohuby M, Stoehr BJ, Menhofer D, Bidlingmaier M, Kienzle E. Effects of low-carbohy-
drate, high-fat diets on apparent digestibility of minerals and trace elements in rats. Nutrition. 2014;
30:869–75. https://doi.org/10.1016/j.nut.2013.11.017 PMID: 24985005
6. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatr Nephrol. 2010; 25:583–90. https://doi.org/10.
1007/s00467-009-1260-4 PMID: 19626341
7. Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, et al. Fibroblast growth factor-23 and car-
diovascular events in CKD. J Am Soc Nephrol. 2014; 25:349–60. https://doi.org/10.1681/ASN.
2013050465 PMID: 24158986
8. Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, et al. Fibroblast
growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Athero-
sclerosis. Circ Heart Fail. 2014; 7:409–17. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000952
PMID: 24668259
9. Panwar B, Jenny NS, Howard VJ, Wadley VG, Muntner P, Kissela BM, et al. Fibroblast growth factor 23
and risk of incident stroke in community-living adults. Stroke. 2015; 46:322–8. https://doi.org/10.1161/
STROKEAHA.114.007489 PMID: 25563643
10. Raya AI, Rios R, Pineda C, Rodriguez-Ortiz ME, Diez E, Almaden Y, et al. Energy-dense diets increase
FGF23, lead to phosphorus retention and promote vascular calcifications in rats. Sci Rep. 2016;
6:36881. https://doi.org/10.1038/srep36881 PMID: 27841294
11. Kanbay M, Vervoelt M, Cozzolino M, Siriopol D, Covic A, Goldsmith D, et al. Novel faces of fibroblast
growth factor 23 (FGF23): iron deficiency, inflammation, insulin resistance, left ventricular hypertrophy,
proteinuria and acute kidney injury. Calcif Tissue Int. 2017; 100:217–28. https://doi.org/10.1007/
s00223-016-0206-7 PMID: 27826644
12. Muñoz-Castañeda JR, Herencia C, Pendón-Ruiz de Mier MV, Rodriguez-Ortiz ME, Diaz-Tocados JM,
Vergara N, et al. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. FASEB J.
2017; 31:3858–67. https://doi.org/10.1096/fj.201700006R PMID: 28515153
13. Sastre C, Rubio-Navarro A, Buendia I, Gomez-Guerrero C, Blanco C, Mas S, et al. Hyperlipidemia-
associated renal damage decreases klotho expression in kidneys from ApoE knockout mice. PLoS
ONE. 2013; 8:e83713. https://doi.org/10.1371/journal.pone.0083713 PMID: 24386260
14. Poret JM, Souza-Smith F, Marcell SJ, Gaudet DA,Tzeng TH, Braymer HD, et al. High fat diet comsump-
tion differentially affects adipose tissue inflammation and adipocyte size in obesity-prone and obesity-
resistant rats. Int J Obes (Lond). 2018; 42:535–41.
15. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;
33:14–22. https://doi.org/10.1016/j.semnephrol.2012.12.006 PMID: 23374890
16. Biber J, Hernando N, Forster I, Murer H. Regulation of phosphate transport in the proximal tubules. Pflu-
gers Arch—Eur J Physiol. 2009; 458:39–52.
17. Bourgeois S, Capuano P, Stange G, Mühlemann R, Murer H, Biber J, et al. The phosphate transporter
NaPi-IIa determines the rapid adaptation to dietary phosphate intake in the mouse irrespective of persis-
tently high FGF23 levels. Pflugers Arch—Eur J Physiol. 2013; 465:1557–72.
18. Kovesdy CP, Quarles LD. FGF23 from bench to bedside. Am J Physiol Renal Physiol. 2016; 310:
F1168–74. https://doi.org/10.1152/ajprenal.00606.2015 PMID: 26864938
19. Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellström D, Orwoll E, et al. Relation between fibroblast
growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int. 2009; 20:1167–
73. https://doi.org/10.1007/s00198-008-0780-2 PMID: 18974917
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